Orgenesis

(OTC) ORGS

Current Price$0.40

Market Cap$3.92M

Since IPO (2010)+6%

5 Year-99%

1 Year-74%

1 Month-19%

Orgenesis Financials at a Glance

Market Cap

$3.92M

Revenue (TTM)

-$12.87M

Net Income (TTM)

-$43.94M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

227.81 (High)

Dividend

$0.00

Beta (Volatility)

227.81 (High)

Price

$0.40

Volume

Open

$0.05

Price

$0.40

Volume

Open

$0.05

Previous Close

$0.40

Daily Range

$0.05 - $0.40

52-Week Range

$0.00 - $1.51

Estimated Earnings Date

Feb 25, 2026

Dividend

$0.00

Beta (Volatility)

227.81 (High)

Price

$0.40

Volume

Open

$0.05

Previous Close

$0.40

Daily Range

$0.05 - $0.40

52-Week Range

$0.00 - $1.51

Estimated Earnings Date

Feb 25, 2026

ORGS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Orgenesis

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Vered Caplan

Website

www.orgenesis.com

Headquarters

Germantown, MD 20876, US

ORGS Financials

Key Financial Metrics (TTM)

Gross Margin

-1080.19%

Operating Margin

-10120.00%

Net Income Margin

-10445.47%

Return on Equity

-1683.22%

Return on Capital

-3274.48%

Return on Assets

-380.44%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.92M

Shares Outstanding

9.80M

Volume

Avg. Volume

1.16K

Financials (TTM)

Gross Profit

-$18.37M

Operating Income

-$93.26M

EBITDA

-$68.24M

Operating Cash Flow

-$15.48M

Capital Expenditure

-$318.00K

Free Cash Flow

-$15.80M

Cash & ST Invst.

$204.00K

Total Debt

$17.30M

Orgenesis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2024YOY CHG

Revenue

$347.00K

+215.5%

Gross Profit

-$238.00K

-720.7%

Gross Margin

-68.59%

N/A

Market Cap

$3.92M

N/A

Market Cap/Employee

$26.85K

N/A

Employees

146

N/A

Net Income

$9.12M

+344.8%

EBITDA

-$7.66M

-203.0%

Quarterly Fundamentals

Name

Q3 2024YOY CHG

Total Cash

$204.00K

+270.9%

Total Debt

$17.30M

-20.5%

Accounts Receivable

$1.40M

+24.4%

Inventory

$0.00

-100.0%

Long Term Debt

$10.10M

-45.5%

Short Term Debt

$7.19M

+124.3%

Return on Assets

-3.80%

N/A

Return on Invested Capital

28.91%

N/A

Free Cash Flow

-$4.69M

-216.5%

Operating Cash Flow

-$4.63M

-292.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EMMAEmmaus Life Sciences, Inc.

EMMAEmmaus Life Sciences, Inc.$0.01-7.26%

SQZBSQZ Biotechnologies Company

SQZBSQZ Biotechnologies Company$0.02+0.00%

NTRRNeutra Corp.

NTRRNeutra Corp.$0.00+100.00%

BPTHBio-Path Holdings, Inc.

BPTHBio-Path Holdings, Inc.$0.05+42.86%

HXBMHelix BioMedix, Inc.

HXBMHelix BioMedix, Inc.$1.79+0.00%

PAIOFPaion AG

PAIOFPaion AG$0.01+0.00%

IDCNIndocan Resources Inc.

IDCNIndocan Resources Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TAT&T

TAT&T$20.58+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

NOKNokia

NOKNokia$12.07-0.07%

Questions About ORGS

What is the current price of Orgenesis?

Orgenesis is trading at $0.40 per share.

What is the 52-week range for Orgenesis?

Over the past 52 weeks, Orgenesis has traded between $0.00 and $1.51.

How much debt does Orgenesis have?

As of the most recent reporting period, Orgenesis reported total debt of $18.26M.

How much cash does Orgenesis have on hand?

Orgenesis reported $687.00K in cash and cash equivalents in its most recent financial results.

What is Orgenesis’s dividend yield?

Orgenesis does not currently have a dividend yield.

Orgenesis

Orgenesis Financials at a Glance

ORGS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Orgenesis

ORGS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Orgenesis Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ORGS

What is the current price of Orgenesis?

What is the 52-week range for Orgenesis?

How much debt does Orgenesis have?

How much cash does Orgenesis have on hand?

What is Orgenesis’s dividend yield?

Premium Investing Services